Clinical Trial Details
EORTC-30962
Back to Clinical Trials Database
Comparative study of intravesical BCG standard dose long-term maintenance versus BCG 1/3 dose long-term maintenance versus BCG standard dose short-term maintenance versus BCG 1/3 dose short-term maintenance in intermediate and high risk Ta- T1 Papillary Carcinoma of the Urinary Bladder.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 01-Mar-1997 Date Step1 close: 04-Apr-2005 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 1288 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00002990 |
| NCT number | NCT00002990 |
